These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15486979)

  • 21. Stellate cells: a moving target in hepatic fibrogenesis.
    Friedman SL
    Hepatology; 2004 Nov; 40(5):1041-3. PubMed ID: 15486918
    [No Abstract]   [Full Text] [Related]  

  • 22. Comments on the review article: Ascites in cirrhosis: a review of management and complications.
    Koulaouzidis A; Bhat S
    Neth J Med; 2008 Apr; 66(4):177; author reply 178. PubMed ID: 18424869
    [No Abstract]   [Full Text] [Related]  

  • 23. Current concepts in the pathogenesis and management of cirrhotic ascites.
    CANTER JW; ROSENTHAL WS; BARONOFSKY ID
    N Y State J Med; 1961 Mar; 61():913-9. PubMed ID: 13690508
    [No Abstract]   [Full Text] [Related]  

  • 24. Care of the cirrhotic patient.
    Grewal P; Martin P
    Clin Liver Dis; 2009 May; 13(2):331-40. PubMed ID: 19442922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Injection of fibrin glue for temporary treatment of an ascites leak from a ruptured umbilical hernia in a patient with liver cirrhosis.
    Sadik KW; Bonatti H; Schmitt T
    Surgery; 2008 Apr; 143(4):574. PubMed ID: 18374059
    [No Abstract]   [Full Text] [Related]  

  • 26. Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the difference.
    Gerbes AL; Gülberg V
    Hepatology; 2005 Jan; 41(1):217. PubMed ID: 15619245
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic arsenicalism; myxedematous ascites and liver cirrhosis].
    MASOCH T; VALENTE VL; GOLDENBERG M
    Dia Med; 1953 Jul; 25(48):1222-4. PubMed ID: 13083440
    [No Abstract]   [Full Text] [Related]  

  • 28. Cryptococcal ascites and ascitic lymphocytosis in cirrhotic patients.
    Sikorski T; Marcinowska-Suchowierska E
    Am J Med; 2007 Jul; 120(7):e23; author reply e25. PubMed ID: 17602919
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complications of liver cirrhosis: oesophageal varices, ascites and hepato-cellular carcinoma].
    Troillet FX; Halkic N; Froehlich F; Moradpour D; Gonvers JJ; Denys A
    Rev Med Suisse; 2005 Jan; 1(3):249-50, 252-5. PubMed ID: 15770820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of ascites and hyponatremia in cirrhosis.
    Ginès P; Cárdenas A
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pros and cons of TIPS for refractory ascites.
    Sanyal AJ
    J Hepatol; 2005 Dec; 43(6):924-5. PubMed ID: 16246451
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of ascites and hepatic hydrothorax.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Gastroenterol; 2007; 21(1):55-75. PubMed ID: 17223497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of HCV-related end-stage liver disease in HIV-coinfected patients.
    Merchante N; Jiménez-Saenz M; Pineda JA
    AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of ascitis in patients with cirrhosis].
    Arfaoui D; Ajmi S
    Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatology.
    Herrero JI; Prieto J
    Clin Sci (Lond); 1996 Mar; 90(3):162-7. PubMed ID: 8777819
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
    Ainsworth MA; Nielsen OH
    Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatorenal syndrome: terminal stage of major complicances of hepatic cirrhosis].
    Costantino S
    Clin Ter; 2004 Sep; 155(9):361-2. PubMed ID: 15700628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.